Expert Commentary
Treat All. It's the Right Thing to Do.
Dr. Arthur J. Ammann discusses the benefits of early antiretroviral treatment for all HIV-infected individuals regardless of CD4 count or clinical status.
0 Comments
HIV Care: There's Still Work to Be Done
Dr. Paul A. Volberding examines the evolving system of health care payment in the United States and the implications of the recent Supreme Court ruling on the Affordable Care Act for the future of HIV treatment.
0 Comments
Long-Term Testosterone Replacement in HIV-Infected Men: A Call for Reexamination
Drs. Gabriel Chamie and Annie Luetkemeyer discuss the risk and benefits of testosterone replacement therapy and examine the long-term implications for HIV-infected patients receiving antiretroviral treatment.
0 Comments
Med Reconciliation: Bad as a Trip to the Dentist?
Dr. Ian R. McNicholl discusses the benefits of medication reconcillation and offers a list of best practices for primary care providers in managing that task.
0 Comments
Immunologic Nonresponders: Suboptimal CD4 T-Cell Response in Antiretroviral-Treated, HIV-Infected Patients
Dr. Hiroyu Hatano discusses the mechanisms of suboptimal immune recovery in patients receiving antiretroviral treatment and offers suggestions for means of better understanding this increasingly important area of HIV research.
0 Comments
Antiretrovirals Aren't Just for Treatment Anymore...Maybe
Susan Buchbinder, MD, and Albert Liu, MD, discuss the promising results from their recent study of ARVs for HIV prevention in high-risk populations.
0 Comments
Retention in Care for HIV-Infected Patients in Resource-Limited Settings: Challenges and Opportunities
Elvin Geng, MD, MPH, discusses retention in care as a crucial component of successful HIV care in resource-limited settings and an area in need of better methods of study.
0 Comments
HIV Neuroretinal Disorder: A New Complication of Accelerated Aging in the Modern Antiretroviral Therapy Era
In this commentary, Mark Jacobson, MD, discusses HIV neuroretinal disorder, a condition that is common (but incompletely studied) in persons with advanced HIV disease and that may be related to immune dysregulation.
0 Comments




A Cure for HIV
March 2013
Steven G. Deeks, MD
Professor, UCSF Positive Health Program at San Francisco General Hospital
Satish Pillai, PhD (moderator)
Assistant Adjunct Professor of Medicine, UCSF
Drs. Steven G. Deeks and Satish Pillai discuss whether there might be a cure for HIV infection in the future.
0 Comments